Es gab 50 kürzliche Insider-Transaktionen für Assembly Biosciences, Inc. (ASMB), darunter 34 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $50.76M und die gesamten Insider-Verkäufe auf $109.06K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Bjorkquist Jeanette M, White Nicole S, Okazaki Jason A. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ASMB
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-30 |
Bjorkquist Jeanette M |
Pfo and Pao |
Informierter Verkauf |
16 |
$27.49 |
$439.84 |
11,089 |
| 2026-03-30 |
White Nicole S |
Chief Manufacturing Officer |
Informierter Verkauf |
9 |
$27.49 |
$247.41 |
37,477 |
| 2026-03-29 |
Okazaki Jason A |
CEO and President |
RSU-Zuteilung |
94,250 |
- |
- |
111,916 |
| 2026-03-29 |
Delaney William E Iv |
Chief Scientific Officer |
RSU-Zuteilung |
26,000 |
- |
- |
45,642 |
| 2026-03-29 |
Bjorkquist Jeanette M |
Pfo and Pao |
RSU-Zuteilung |
6,500 |
- |
- |
11,417 |
| 2026-03-29 |
White Nicole S |
Chief Manufacturing Officer |
RSU-Zuteilung |
26,000 |
- |
- |
37,674 |
| 2026-03-29 |
Gaggar Anuj |
Chief Medical Officer |
RSU-Zuteilung |
26,000 |
- |
- |
28,000 |
| 2025-08-08 |
Gilead Sciences, Inc. |
10 Percent Owner |
Informierter Kauf |
1,147,960 |
$21.60 |
$24.8M |
1,147,960 |
| 2025-06-16 |
Bjorkquist Jeanette M |
Pfo and Pao |
RSU-Zuteilung |
600 |
$17.24 |
$10.34K |
600 |
| 2025-06-05 |
Altig Anthony E |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Ringo William R |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Mahony Susan |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Consylman Gina |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Mchutchison John G |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Johnson-pratt Lisa |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-06-05 |
Houghton Michael |
Director |
RSU-Zuteilung |
3,500 |
$15.81 |
$55.34K |
3,500 |
| 2025-03-31 |
Okazaki Jason A |
CEO and President |
Informierter Verkauf |
355 |
$9.85 |
$3.5K |
14,757 |
| 2025-03-31 |
Bjorkquist Jeanette M |
Principal Accounting Officer |
Informierter Verkauf |
180 |
$9.85 |
$1.77K |
4,617 |
| 2025-03-31 |
White Nicole S |
Chief Manufacturing Officer |
Informierter Verkauf |
197 |
$9.85 |
$1.94K |
11,674 |
| 2025-03-31 |
Mchutchison John G |
Director |
Informierter Verkauf |
757 |
$9.85 |
$7.46K |
18,347 |
| 2025-03-29 |
Okazaki Jason A |
CEO and President |
RSU-Zuteilung |
71,100 |
$10.62 |
$755.08K |
71,100 |
| 2025-03-29 |
Delaney William E Iv |
Chief Scientific Officer |
RSU-Zuteilung |
25,500 |
$10.62 |
$270.81K |
25,500 |
| 2025-03-29 |
Bjorkquist Jeanette M |
Principal Accounting Officer |
RSU-Zuteilung |
1,900 |
$10.62 |
$20.18K |
1,900 |
| 2025-03-29 |
White Nicole S |
Chief Manufacturing Officer |
RSU-Zuteilung |
20,400 |
$10.62 |
$216.65K |
20,400 |
| 2025-03-29 |
Gaggar Anuj |
Chief Medical Officer |
RSU-Zuteilung |
24,200 |
$10.62 |
$257K |
24,200 |
| 2024-12-30 |
Houghton Michael |
Director |
Informierter Kauf |
3,202 |
$15.61 |
$50K |
3,202 |
| 2024-12-19 |
Gilead Sciences, Inc. |
10 Percent Owner |
Informierter Kauf |
940,499 |
$21.37 |
$20.1M |
2,209,471 |
| 2024-11-25 |
Schornstein Alexander |
10 Percent Owner |
Informierter Kauf |
2,976 |
$15.00 |
$44.64K |
723,113 |
| 2024-11-22 |
Schornstein Alexander |
10 Percent Owner |
Informierter Kauf |
17,024 |
$14.87 |
$253.1K |
720,137 |
| 2024-11-18 |
White Nicole S |
Chief Manufacturing Officer |
Informierter Verkauf |
40 |
$16.29 |
$651.60 |
11,871 |
| 2024-10-08 |
Schornstein Alexander |
10 Percent Owner |
Informierter Kauf |
10,000 |
$14.58 |
$145.8K |
703,113 |
| 2024-10-03 |
Okazaki Jason A |
CEO and President |
Informierter Verkauf |
197 |
$14.81 |
$2.92K |
14,904 |
| 2024-10-03 |
White Nicole S |
Chief Manufacturing Officer |
Informierter Verkauf |
157 |
$14.81 |
$2.33K |
11,911 |
| 2024-08-02 |
Okazaki Jason A |
CEO and President |
Informierter Verkauf |
981 |
$14.23 |
$13.96K |
15,101 |
| 2024-08-02 |
White Nicole S |
Chief Manufacturing Officer |
Informierter Verkauf |
785 |
$14.23 |
$11.17K |
12,068 |
| 2024-07-05 |
Schornstein Alexander |
10 Percent Owner |
Informierter Kauf |
4,438 |
$12.52 |
$55.56K |
693,113 |
| 2024-07-03 |
Schornstein Alexander |
10 Percent Owner |
Informierter Kauf |
4,562 |
$12.29 |
$56.07K |
688,675 |
| 2024-06-17 |
Gilead Sciences, Inc. |
10 Percent Owner |
Informierter Kauf |
179,500 |
$17.00 |
$3.05M |
179,500 |
| 2024-05-29 |
Altig Anthony E |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Ringo William R |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Mahony Susan |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Consylman Gina |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Mchutchison John G |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Johnson-pratt Lisa |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-29 |
Houghton Michael |
Director |
RSU-Zuteilung |
2,750 |
$15.06 |
$41.42K |
2,750 |
| 2024-05-23 |
Mchutchison John G |
Director |
Informierter Verkauf |
2,117 |
$14.93 |
$31.61K |
19,104 |
| 2024-05-23 |
Okazaki Jason A |
CEO and President |
Informierter Verkauf |
549 |
$14.93 |
$8.2K |
16,082 |
| 2024-05-23 |
Bjorkquist Jeanette M |
Principal Accounting Officer |
Informierter Verkauf |
24 |
$14.93 |
$358.41 |
3,142 |
| 2024-05-23 |
White Nicole S |
Chief Manufacturing Officer |
Informierter Verkauf |
172 |
$14.93 |
$2.57K |
12,853 |
| 2024-04-30 |
Okazaki Jason A |
CEO and President |
Informierter Verkauf |
1,569 |
$12.71 |
$19.94K |
16,423 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
